Esperion Therapeutics Stock (NASDAQ: ESPR) stock price, news, charts, stock research, profile.
You can purchase shares of Esperion Therapeutics (NASDAQ:ESPR) through any online brokerage.
Other companies in Esperion Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
Esperion Therapeutics has a consensus price target of $7.69.
The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $2.1801 last updated December 20, 2024 at 7:56 PM EST.
There are no upcoming dividends for Esperion Therapeutics.
Esperion Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Esperion Therapeutics.
Esperion Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.